233 related articles for article (PubMed ID: 38413714)
1. Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity.
Dong H; He X; Zhang L; Chen W; Lin YC; Liu SB; Wang H; Nguyen LXT; Li M; Zhu Y; Zhao D; Ghoda L; Serody J; Vincent B; Luznik L; Gojo I; Zeidner J; Su R; Chen J; Sharma R; Pirrotte P; Wu X; Hu W; Han W; Shen B; Kuo YH; Jin J; Salhotra A; Wang J; Marcucci G; Luo YL; Li L
Nat Cancer; 2024 Apr; 5(4):601-624. PubMed ID: 38413714
[TBL] [Abstract][Full Text] [Related]
2. PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD
He X; Zhu Y; Lin YC; Li M; Du J; Dong H; Sun J; Zhu L; Wang H; Ding Z; Zhang L; Zhang L; Zhao D; Wang Z; Wu H; Zhang H; Jiang W; Xu Y; Jin J; Shen Y; Perry J; Zhao X; Zhang B; Liu S; Xue SL; Shen B; Chen CW; Chen J; Khaled S; Kuo YH; Marcucci G; Luo Y; Li L
Blood; 2019 Aug; 134(6):548-560. PubMed ID: 31217189
[TBL] [Abstract][Full Text] [Related]
3. Unique Features of Human Protein Arginine Methyltransferase 9 (PRMT9) and Its Substrate RNA Splicing Factor SF3B2.
Hadjikyriacou A; Yang Y; Espejo A; Bedford MT; Clarke SG
J Biol Chem; 2015 Jul; 290(27):16723-43. PubMed ID: 25979344
[TBL] [Abstract][Full Text] [Related]
4. Arginine methyltransferase PRMT5 negatively regulates cGAS-mediated antiviral immune response.
Ma D; Yang M; Wang Q; Sun C; Shi H; Jing W; Bi Y; Shen X; Ma X; Qin Z; Lin Y; Zhu L; Zhao Y; Cheng Y; Han L
Sci Adv; 2021 Mar; 7(13):. PubMed ID: 33762328
[TBL] [Abstract][Full Text] [Related]
5. Nuclear cGAS Functions Non-canonically to Enhance Antiviral Immunity via Recruiting Methyltransferase Prmt5.
Cui S; Yu Q; Chu L; Cui Y; Ding M; Wang Q; Wang H; Chen Y; Liu X; Wang C
Cell Rep; 2020 Dec; 33(10):108490. PubMed ID: 33296647
[TBL] [Abstract][Full Text] [Related]
6. PRMT9 is a type II methyltransferase that methylates the splicing factor SAP145.
Yang Y; Hadjikyriacou A; Xia Z; Gayatri S; Kim D; Zurita-Lopez C; Kelly R; Guo A; Li W; Clarke SG; Bedford MT
Nat Commun; 2015 Mar; 6():6428. PubMed ID: 25737013
[TBL] [Abstract][Full Text] [Related]
7. Loss-of-function mutation in PRMT9 causes abnormal synapse development by dysregulation of RNA alternative splicing.
Shen L; Ma X; Wang Y; Wang Z; Zhang Y; Pham HQH; Tao X; Cui Y; Wei J; Lin D; Abeywanada T; Hardikar S; Halabelian L; Smith N; Chen T; Barsyte-Lovejoy D; Qiu S; Xing Y; Yang Y
Nat Commun; 2024 Apr; 15(1):2809. PubMed ID: 38561334
[TBL] [Abstract][Full Text] [Related]
8. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling.
Jiang H; Zhou Z; Jin S; Xu K; Zhang H; Xu J; Sun Q; Wang J; Xu J
Cancer Sci; 2018 May; 109(5):1414-1427. PubMed ID: 29603830
[TBL] [Abstract][Full Text] [Related]
9. Decoding m
Cheng Y; Gao Z; Zhang T; Wang Y; Xie X; Han G; Li Y; Yin R; Chen Y; Wang P; Hu J; Zhang T; Guo C; Chai J; Wang J; Cui M; Gao K; Liu W; Yao S; Lu P; Cao Z; Zheng Y; Chang J; Liu Z; Song Q; Li W; Zhou F; Zhang H
Cell Stem Cell; 2023 Jan; 30(1):69-85.e7. PubMed ID: 36574771
[TBL] [Abstract][Full Text] [Related]
10. Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells.
Cook AM; Li L; Ho Y; Lin A; Li L; Stein A; Forman S; Perrotti D; Jove R; Bhatia R
Blood; 2014 May; 123(18):2826-37. PubMed ID: 24668492
[TBL] [Abstract][Full Text] [Related]
11. Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia.
Jin Y; Zhou J; Xu F; Jin B; Cui L; Wang Y; Du X; Li J; Li P; Ren R; Pan J
J Clin Invest; 2016 Oct; 126(10):3961-3980. PubMed ID: 27643437
[TBL] [Abstract][Full Text] [Related]
12. circFAM193B interaction with PRMT6 regulates AML leukemia stem cells chemoresistance through altering the oxidative metabolism and lipid peroxidation.
Yang X; Liu J; Liu W; Wu H; Wei Y; Guo X; Jia H; Can C; Wang D; Hu X; Ma D
Leukemia; 2024 May; 38(5):1057-1071. PubMed ID: 38424136
[TBL] [Abstract][Full Text] [Related]
13. PRMT9 inhibition sparks immune responses in AML.
Santoro A; Di Micco R
Nat Cancer; 2024 Apr; 5(4):539-541. PubMed ID: 38684824
[No Abstract] [Full Text] [Related]
14. FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues.
Cook JR; Lee JH; Yang ZH; Krause CD; Herth N; Hoffmann R; Pestka S
Biochem Biophys Res Commun; 2006 Apr; 342(2):472-81. PubMed ID: 16487488
[TBL] [Abstract][Full Text] [Related]
15. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B
Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745
[TBL] [Abstract][Full Text] [Related]
16. RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression.
Jajosky AN; Coad JE; Vos JA; Martin KH; Senft JR; Wenger SL; Gibson LF
Stem Cells Transl Med; 2014 Jul; 3(7):836-48. PubMed ID: 24855276
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells.
Jin L; Lee EM; Ramshaw HS; Busfield SJ; Peoppl AG; Wilkinson L; Guthridge MA; Thomas D; Barry EF; Boyd A; Gearing DP; Vairo G; Lopez AF; Dick JE; Lock RB
Cell Stem Cell; 2009 Jul; 5(1):31-42. PubMed ID: 19570512
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1α protein.
Zhang H; Guo X; Feng X; Wang T; Hu Z; Que X; Tian Q; Zhu T; Guo G; Huang W; Li X
Oncotarget; 2017 Jan; 8(2):2342-2355. PubMed ID: 27911265
[TBL] [Abstract][Full Text] [Related]
19. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor.
Feoli A; Iannelli G; Cipriano A; Milite C; Shen L; Wang Z; Hadjikyriacou A; Lowe TL; Safaeipour C; Viviano M; Sarno G; Morretta E; Monti MC; Yang Y; Clarke SG; Cosconati S; Castellano S; Sbardella G
J Med Chem; 2023 Oct; 66(19):13665-13683. PubMed ID: 37560786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
